SCHEMBL1103443

SCHEMBL1103443

C[Si]1(C)c2ccccc2N(c2c3ccccc3c(-c3ccccc3)c3c2cnc2ccccc23)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 3/20 0.36
ALDH1A1 P00352 5/20 0.34
HTT P42858 3/20 0.34
NPSR1 Q6W5P4 3/20 0.34
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HPGD P15428 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2D6 P10635 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
POLB P06746 2/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103326 0.89 TLR7 (0.35) TLR7KDM4E
SCHEMBL1103550 0.88 MET (0.37) TLR7MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL1103602 0.85 PDE10A (0.33) TLR7POLBKDM4E
SCHEMBL1103442 0.83 TLR7 (0.35) TLR7ALDH1A1HTTNPSR1MAPT
SCHEMBL1103432 0.82 TLR7 (0.36) TLR7ALDH1A1HTTNPSR1MAPT
SCHEMBL1103441 0.82 TLR7 (0.34) TLR7ALDH1A1HTTNPSR1MAPT
SCHEMBL1103445 0.82 CDK4 (0.37) TLR7ALDH1A1HTTNPSR1MAPT
SCHEMBL1103345 0.79 ADORA3 (0.30)
SCHEMBL1103092 0.77 PAX8 (0.32) ALDH1A1HTTMAPTHPGDCYP2C19
SCHEMBL1102773 0.77 ALOX5 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TLR7 2008/4885ALDH1A1 1015/4885HTT 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.